Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 15/20 | 0.81 |
| ▸ | AVPR1A | P37288 | 8/20 | 0.81 |
| ▸ | AVPR2 | P30518 | 7/20 | 0.81 |
| ▸ | AVPR1B | P47901 | 6/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demoxytocin SCHEMBL38443 | 0.94 | AVPR1A (0.88) | OXTRAVPR1AAVPR2AVPR1B | |
| Demoxytocin SCHEMBL38442 | 0.94 | AVPR1A (0.88) | OXTRAVPR1AAVPR2AVPR1B | |
| Demoxytocin SCHEMBL29376547 | 0.94 | AVPR1A (0.88) | OXTRAVPR1AAVPR2AVPR1B | |
| SCHEMBL15511632 | 0.93 | AVPR1A (0.80) | OXTRAVPR1AAVPR2AVPR1B | |
| Oxytocin SCHEMBL28086558 | 0.92 | OXTR (0.93) | OXTRAVPR1AAVPR2AVPR1B | |
| Oxytocin Trisulfide SCHEMBL30712243 | 0.91 | AVPR1A (0.86) | OXTRAVPR1AAVPR2AVPR1B | |
| SCHEMBL15511706 | 0.91 | AVPR1A (0.76) | OXTRAVPR1AAVPR2AVPR1B | |
| SCHEMBL21255736 | 0.90 | OXTR (0.72) | OXTRAVPR1AAVPR2AVPR1B | |
| Carbetocin SCHEMBL23118157 | 0.89 | OXTR (1.00) | OXTRAVPR1AAVPR2AVPR1B | |
| Carbetocin SCHEMBL39224 | 0.89 | OXTR (1.00) | OXTRAVPR1AAVPR2AVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250299335-A1 | FLUORESCENCE-BASED DETECTION OF PROBLEMATIC CELLULAR ENTITIES | KENT IMAGING INC. (CA) | 2025-09-25 | — | — | US | claimed |
| US-12354266-B2 | Fluorescence-based detection of problematic cellular entities | ADIUVO DIAGNOSTICS PRIVATE LIMITED (IN) | 2025-07-08 | — | — | US | claimed |
| US-20250143963-A1 | SYSTEM AND METHOD FOR OPTIMIZATION OF CPR CHEST COMPRESSIONS | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 2025-05-08 | — | — | US | claimed |
| US-20240362781-A1 | FLUORESCENCE-BASED DETECTION OF PROBLEMATIC CELLULAR ENTITIES | KENT IMAGING INC. (CA) | 2024-10-31 | — | — | US | claimed |
| US-12121493-B2 | System and method for optimization of CPR chest compressions | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2024-10-22 | — | — | US | claimed |
| US-12094117-B2 | Fluorescence-based detection of problematic cellular entities | ADIUVO DIAGNOSTICS PRIVATE LIMITED (IN) | 2024-09-17 | — | — | US | claimed |
| US-20240046474-A1 | FLUORESCENCE-BASED DETECTION OF PROBLEMATIC CELLULAR ENTITIES | KENT IMAGING INC. (CA) | 2024-02-08 | — | — | US | claimed |
| US-20230322549-A1 | METHODS AND SYSTEMS FOR CRYOGENICALLY SEPARATING CARBON DIOXIDE AND HYDROGEN FROM A SYNGAS STREAM | Decarbtek Global Corp. (CA) | 2023-10-12 | — | — | US | claimed |
| US-11478151-B2 | Fiber optic flow and oxygenation monitoring using diffuse correlation and reflectance | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-10-25 | — | — | US | claimed |
| US-12629068-B2 | Detecting and correcting for interference in an analyte monitoring system | SENSEONICS INCORPORATED (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4697979-A1 | METHOD OF PRODUCING A MODIFIED PROTEIN COMPOSITION BY REACTION WITH OXIDIZED PHENOLIC COMPOUNDS, THE MODIFIED PROTEIN COMPOSITION, AND NUTRITIONAL USES OF THE MODIFIED PROTEIN COMPOSITION | Arla Foods amba (DK) | 2026-02-25 | — | — | EP | disclosed |
| US-20260041322-A1 | System And Devices For Multispectral 3D Imaging And Diagnostics Of Tissues, And Methods Thereof | COLGATE-PALMOLIVE COMPANY (US) | 2026-02-12 | — | — | US | disclosed |
| EP-3472803-B1 | METHOD AND APPARATUS FOR ESTIMATING THE VALUE OF A PHYSICAL PARAMETER IN A BIOLOGICAL TISSUE | UCL BUSINESS LTD (GB) | 2026-01-21 | — | — | EP | disclosed |
| EP-4652307-A1 | HYDROGEN PLANT | Green Hydrogen Systems A/S (DK) | 2025-11-26 | — | — | EP | disclosed |
| WO-2022169544-A1 | SYSTEM AND DEVICES FOR MULTISPECTRAL 3D IMAGING AND DIAGNOSTICS OF TISSUES, AND METHODS THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2022-08-11 | — | — | WO | disclosed |
| US-20220240786-A1 | System and Devices for Multispectral 3D Imaging and Diagnostics of Tissues, and Methods Thereof | COLGATE-PALMOLIVE COMPANY (US) | 2022-08-04 | — | — | US | disclosed |
| EP-2763588-B1 | VIRTUAL REALITY FOR MOVEMENT DISORDER DIAGNOSIS | MEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT (IL) | 2022-07-06 | — | — | EP | disclosed |
| US-20220087983-A1 | ACTIVATING PYRUVATE KINASE R | FORMA THERAPEUTICS INC (US) | 2022-03-24 | — | — | US | disclosed |
| US-20220054015-A1 | OPTICAL METHOD FOR GINGIVITIS DETECTION | KONINKLIJKE PHILIPS N.V. (NL) | 2022-02-24 | — | — | US | disclosed |
| US-20140066373-A1 | TREATING DIABETES WITH OXYTOCIN OR OXYTOCIN ANALOGS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2014-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629068-B2 | Detecting and correcting for interference in an analyte monitoring system | SLC2A8, SLC2A2, SLC2A1 | OXTR 2248/4885AVPR1A 544/4885AVPR2 437/4885 |
| US-20260041322-A1 | System And Devices For Multispectral 3D Imaging And Diagnostics Of Tissues, And Methods Thereof | HTR3D, TLR3, MMP3 | OXTR 3681/4885AVPR1A 4613/4885AVPR2 4759/4885 |
| US-20220087983-A1 | ACTIVATING PYRUVATE KINASE R | PCK1, PDK1, PHKG1 | OXTR 3308/4885AVPR1A 4015/4885AVPR2 4147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.